CALL US TODAY FOR A FREE CONSULTATION: 800.545.3737 - 617.742.1900|HELP@SWARTZLAW.COM

Fen/Phen

Woman enrolled in a weight loss program conducted by a Research Center. Under the watch of the Center, the woman was administered the drugs fenfluramine (“fen”) and phentermine (“phen”) also known as “fen/phen”. As a result of this weight loss program and the carelessness, negligence, and breaches of warranties by the Center and the drug manufacturer, the woman sustained a disabling stroke, leaving her permanently disabled.[92]

Facebook Comments
By |2018-07-11T14:57:56+00:00July 11th, 2018|Products Liability - Medications|0 Comments

About the Author:

Swartz & Swartz